News in brief: Cannabidiol on PBS for Dravet syndrome; TBI linked to mental health in kids; Zostavax stroke prevention strategy

Cannabidiol on PBS for  Dravet Syndrome A cannabidiol product, Epidyolex, will be available on the PBS from 1 May for third line treatment of Dravet Syndrome (DS) in combination with at least two other anti-epileptic drugs (AEDs). The listing is expected to provide access treatment for around 116 patients each year, who might otherwise pay ...

Already a member?

Login to keep reading.

© 2021 the limbic